Robert Ang's Insider Trades & SAST Disclosures
Robert Ang's most recent trade in Vor Biopharma Inc was a trade of 2,787 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on Feb. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Ang.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 06 Feb 2025 | 2,787 | 918,952 | - | 1.5 | 4,181 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 825,000 | 825,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 652,086 | 652,086 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 652,086 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 470,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 470,000 | 470,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 376,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 376,000 | 376,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 257,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 257,500 | 257,500 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 172,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 172,500 | 172,500 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 147,294 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 147,294 | 147,294 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 137,500 | 921,739 | - | 0 | Common Stock | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 51,060 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 51,060 | 51,060 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.34 per share. | 03 Feb 2025 | 3,248 | 784,239 | - | 1.3 | 4,352 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 06 Nov 2024 | 2,361 | 787,487 | - | 0.9 | 2,030 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 01 Nov 2024 | 2,751 | 789,848 | - | 0.8 | 2,201 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 03 Sep 2024 | 12,657 | 792,599 | - | 0.8 | 10,505 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 06 Aug 2024 | 2,361 | 805,256 | - | 0.9 | 2,054 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 01 Aug 2024 | 2,751 | 807,617 | - | 0.9 | 2,586 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.75 per share. | 06 May 2024 | 2,361 | 810,368 | - | 1.8 | 4,132 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 01 May 2024 | 2,751 | 812,729 | - | 1.8 | 4,869 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. | 01 Mar 2024 | 12,657 | 815,480 | - | 2.3 | 28,731 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.32 per share. | 06 Feb 2024 | 2,788 | 828,137 | - | 2.3 | 6,468 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 470,000 | 470,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 150,000 | 830,925 | - | 0 | Common Stock | |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.67 per share. | 07 Aug 2023 | 2,361 | 695,943 | - | 2.7 | 6,304 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 08 May 2023 | 2,361 | 698,304 | - | 4.1 | 9,775 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.51 per share. | 01 Mar 2023 | 12,657 | 700,665 | - | 5.5 | 69,740 | Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 257,500 | 257,500 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 128,750 | 713,322 | - | 0 | Common Stock | |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2022 | 172,500 | 172,500 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2022 | 172,500 | 584,572 | - | 0 | Common Stock | |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 376,000 | 376,000 | - | - | Employee Stock Option (right to buy) | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Nov 2021 | 3,661 | 13,043 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 1,939 | 16,704 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 794 | 6,351 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 713 | 2,852 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 432 | 5,096 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 7,378 | 14,765 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2021 | 1,680 | 8,047 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2021 | 794 | 7,145 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2021 | 713 | 3,565 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 206.51 per share. | 01 Aug 2021 | 660 | 7,387 (0%) | 0% | 206.5 | 136,297 | Common Stock |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2021 | 173 | 5,528 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 1,679 | 7,026 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 794 | 7,939 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 713 | 4,278 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 186.76 per share. | 30 Apr 2021 | 659 | 6,367 (0%) | 0% | 186.8 | 123,075 | Common Stock |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Other type of transaction at price $ 111.54 per share. | 30 Apr 2021 | 191 | 5,347 (0%) | 0% | 111.5 | 21,305 | Common Stock |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 172 | 5,701 | - | - | Restricted Stock Unit | |
| Vor Biopharma Inc | Robert Ang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 51,060 | 51,060 | - | - | Employee Stock Option (right to buy) | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 1,679 | 5,842 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 793 | 8,733 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 713 | 4,991 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 196.35 per share. | 01 Feb 2021 | 686 | 5,156 (0%) | 0% | 196.3 | 134,696 | Common Stock |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 173 | 5,873 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 9,526 | 9,526 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 2,653 | 4,661 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.94 per share. | 30 Oct 2020 | 1,389 | 4,163 (0%) | 0% | 132.9 | 184,654 | Common Stock |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2020 | 885 | 5,552 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2020 | 713 | 5,704 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2020 | 172 | 6,046 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Other type of transaction at price $ 0.00 per share. | 30 Oct 2020 | 6 | 4,667 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2020 | 1,403 | 2,559 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2020 | 713 | 6,417 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2020 | 690 | 6,218 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.90 per share. | 01 Aug 2020 | 551 | 2,008 (0%) | 0% | 135.9 | 74,881 | Common Stock |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Sale of securities on an exchange or to another person at price $ 132.16 per share. | 04 May 2020 | 288 | 1,156 (0%) | 0% | 132.2 | 38,061 | Common Stock |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 713 | 7,130 | - | - | Restricted Stock Unit | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 713 | 1,444 (0%) | 0% | 0 | Common Stock | |
| F5 Inc | Angus Donald Winton Robertson | SVP & GM, Nginx | Other type of transaction at price $ 118.37 per share. | 30 Apr 2020 | 336 | 731 (0%) | 0% | 118.4 | 39,773 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges